The global Metagenomics Market is expanding as researchers, pharmaceutical companies, healthcare organizations, and biotechnology firms increasingly use genomic technologies to analyze microbial communities. Metagenomics enables researchers to study genetic material obtained directly from environmental or biological samples without requiring individual microorganisms to be cultured separately.
The technology is increasingly being applied in healthcare, pharmaceuticals, agriculture, environmental research, food safety, biotechnology, and infectious disease monitoring. Growing interest in microbiome research and precision medicine is also creating new opportunities.
According to Fortune Business Insights, the global Metagenomics Market was valued at approximately USD 2.99 billion in 2025 and is projected to grow from USD 3.40 billion in 2026 to USD 9.52 billion by 2034, exhibiting a CAGR of 13.73% during the forecast period.
The increasing adoption of next-generation sequencing is a major growth factor. Sequencing technologies allow researchers to analyze microbial communities more quickly and obtain detailed genetic information.
Metagenomics is increasingly used for:
Growing investments in genomic research and bioinformatics are further supporting market expansion.
NGS technologies are improving the speed, accuracy, and accessibility of microbial genomic analysis. This is allowing laboratories and research institutions to study increasingly complex microbial populations.
Artificial intelligence and advanced bioinformatics tools are helping researchers process large genomic datasets. Automated analysis can identify patterns and relationships that would be difficult to evaluate manually.